ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
77 hedge funds and large institutions have $109M invested in Adamas Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
70% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 27
Holders
77
Holding in Top 10
2
Calls
$542K
Puts
$441K
Top Buyers
| 1 | +$3.87M | |
| 2 | +$2.72M | |
| 3 | +$1.41M | |
| 4 |
KA
Kerrisdale Advisers
Miami,
Florida
|
+$995K |
| 5 |
BlackRock
New York
|
+$696K |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$7.47M | |
| 3 | -$5.75M | |
| 4 |
Millennium Management
New York
|
-$4.29M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.54M |